PFIZER INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
Phase 4
Completed
- Conditions
- Encephalitis, Tick-Borne
- Interventions
- Biological: FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2018-12-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 179
- Registration Number
- NCT00894686
- Locations
- 🇦🇹
Grieskirchnerstr.17, Oberösterreich, Austria
🇦🇹Untergraben 2, Oberösterreich, Austria
🇩🇪Dr. Ulrich Behre, Baden-Württemberg, Germany
Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Other: Review of clinical records
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2011-07-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 321
- Registration Number
- NCT00895050
A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects
Phase 1
Completed
- Conditions
- Falciparum Malaria
- Interventions
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2010-04-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 38
- Registration Number
- NCT00894660
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
Non-Interventional Study With Aricept® Evess
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2011-03-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 370
- Registration Number
- NCT00889603
- Locations
- 🇷🇴
Pfizer Investigational Site, Iasi, Romania
A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2011-10-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT00889720
- Locations
- 🇮🇹
Pfizer Investigational Site, Pisa, Italy
Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2009-04-27
- Last Posted Date
- 2012-02-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 441
- Registration Number
- NCT00888576
- Locations
- 🇨🇳
Pfizer Investigational Site, Taoyuan, Taiwan
Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Phase 3
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 874
- Registration Number
- NCT00887224
- Locations
- 🇿🇦
Pfizer Investigational Site, Paarl, South Africa
Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 19
- Registration Number
- NCT00886743
- Locations
- 🇺🇸
Pfizer Investigational Site, Laredo, Texas, United States
🇺🇸Sarcoma Oncology Center, Santa Monica, California, United States
🇺🇸Howard University, Washington, District of Columbia, United States
A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Biological: CVX-096
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 114
- Registration Number
- NCT00886821
- Locations
- 🇺🇸
Cetero Research, Miami Gardens, Florida, United States
🇺🇸Cetero Research - San Antonio, San Antonio, Texas, United States
A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants
- First Posted Date
- 2009-04-22
- Last Posted Date
- 2009-07-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT00886093
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States